VistaGen’s nasal spray could reduce menopausal hot flashes, new data suggests
In new Phase IIa data, VistaGen's nasal spray reduced the average number of hot flashes in women with menopause.

In new Phase IIa data, VistaGen's nasal spray reduced the average number of hot flashes in women with menopause.
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
The future of long Covid trials
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan